CLLS - Cellectis S A Stock Trading

Cellectis S.A.(NASDAQ: CLLS) stock trading, description, contact, officers and directors.

About Cellectis S.A.

Not available

Stock Information

Cellectis S.A. Company Name:

CLLS Stock Symbol:

NASDAQ Market:

Get CLLS Alerts

News, Short Squeeze, Breakout and More Instantly...

CLLS - Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST

NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that it will report its financial results for...
CLLS - Calyxt Announces $15 Million Registered Direct Offering

NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today that its majority-owned subsidiary Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has entered into definitive agreements with institutional investors for...
CLLS - Cellectis to Participate in Upcoming Investor Conferences

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), will present at several upcoming investor conferences. We...